Following years of research and investment, liquid biopsies are steadily accumulating FDA approvals. The tests are being used in molecular profiling of solid tumors and as companion diagnostics for targeted cancer therapies.
The company plans to discontinue development of its intravenous drug, SY-1365, and refocus on an oral therapy with the same molecular target following the former's failure in Phase I. Shares of Syros fell more than 32 percent on the news.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Instead of making money the reward for its digital health startup pitch contest, Brigham and Women’s Hospital iHub innovation center put another hot commodity up for grabs: collaboration with clinicians and executives. Ten finalists competed in its Shark Tank-style innovation contest this week. They were all solutions that addressed either the patient and family experience […]
Overcoming challenges posed by the growing number of infections that are resistant to traditional antibiotics is the goal of a startup surfacing today with a $3 million Series A and a drug development partnership with Roche. Spero Therapeutics was born last year out of a collaboration between VC firm Atlas Venture’s seed program and Partners […]
Athenahealth CEO Jonathan Bush and Tim Draper of Draper Fisher Jurvetson are just two of the investors seeding a startup that turns a doctor’s orders into easy-to-digest, personalized care plans. Rock Health grad Wellframe just rounded up $1.5 million to grow its team and business development efforts, according to CEO Jacob Sattelmair. Bush and Draper […]
The city of Boston and Boston Medical Center have come up with a creative new way to address both health and transportation issues for low-income residents struggling with obesity. Under the new Prescribe-a-Bike program, BMC doctors will be able to “prescribe” $5 memberships to Hubway, a bike-sharing program in the greater Boston area, to obese […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Boston medical device startup Cre8MDI is automating an old technique with the hope of giving doctors another inexpensive tool they could use in-office to help predict, detect and monitor heart disease. The metric Cre8MDI is capturing with its sensor device is arterial stiffness. Over the last decade and a half, a growing body of literature […]